Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany Pascreau

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 10, 2021
SLC37A4-CDG: New biochemical insights for an emerging congenital disorder of glycosylation with major coagulopathyAlexandre Raynor, Walid Haouari, Bobby G Ng, et al.
Journal of Cardiothoracic and Vascular Anesthesia|December 9, 2021
Blood Lactate During Double-Lung Transplantation: A Predictor of Grade-3 Primary Graft DysfunctionJulien Fessler, Alexandre Vallée, Avit Guirimand, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 9, 2018
Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?Peter Witters, Tomas Honzik, Eric Bauchart, et al.
Journal of Thrombosis and Haemostasis : JTH|July 5, 2019
Elevated thrombin generation in patients with congenital disorder of glycosylation and combined coagulation factor deficienciesTiffany Pascreau, Maria E de la Morena-Barrio, Dominique Lasne, et al.
Haematologica|August 18, 2018
A mutation in the gene coding for the sialic acid transporter SLC35A1 is required for platelet life span but not proplatelet formationAlexandre Kauskot, Tiffany Pascreau, Frédéric Adam, et al.
British Journal of Haematology|January 21, 2021
Assessing bleeding risk in 18 children with Osteogenesis imperfectaTeddy Léguillier, Rémi Favier, Annie Harroche, et al.
Journal of Inherited Metabolic Disease|April 9, 2020
Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylationAnna Čechová, Ruqaiah Altassan, Delphine Borgel, et al.
Molecular Genetics and Metabolism|August 5, 2023
Association between acute complications in PMM2-CDG patients and haemostasis anomalies: Data from a multicentric study and suggestions for acute managementCamille Wicker, Charles-Joris Roux, Louise Goujon, et al.
American Journal of Human Genetics|May 8, 2021
A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunctionBobby G Ng, Paulina Sosicka, François Fenaille, et al.
Journal of Medical Genetics|September 29, 2017
Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literatureManuel Schiff, Céline Roda, Marie-Lorraine Monin, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 10, 2021
SLC37A4-CDG: New biochemical insights for an emerging congenital disorder of glycosylation with major coagulopathyAlexandre Raynor, Walid Haouari, Bobby G Ng, et al.
Journal of Cardiothoracic and Vascular Anesthesia|December 9, 2021
Blood Lactate During Double-Lung Transplantation: A Predictor of Grade-3 Primary Graft DysfunctionJulien Fessler, Alexandre Vallée, Avit Guirimand, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 9, 2018
Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?Peter Witters, Tomas Honzik, Eric Bauchart, et al.
Journal of Thrombosis and Haemostasis : JTH|July 5, 2019
Elevated thrombin generation in patients with congenital disorder of glycosylation and combined coagulation factor deficienciesTiffany Pascreau, Maria E de la Morena-Barrio, Dominique Lasne, et al.
Haematologica|August 18, 2018
A mutation in the gene coding for the sialic acid transporter SLC35A1 is required for platelet life span but not proplatelet formationAlexandre Kauskot, Tiffany Pascreau, Frédéric Adam, et al.
British Journal of Haematology|January 21, 2021
Assessing bleeding risk in 18 children with Osteogenesis imperfectaTeddy Léguillier, Rémi Favier, Annie Harroche, et al.
Journal of Inherited Metabolic Disease|April 9, 2020
Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylationAnna Čechová, Ruqaiah Altassan, Delphine Borgel, et al.
Molecular Genetics and Metabolism|August 5, 2023
Association between acute complications in PMM2-CDG patients and haemostasis anomalies: Data from a multicentric study and suggestions for acute managementCamille Wicker, Charles-Joris Roux, Louise Goujon, et al.
American Journal of Human Genetics|May 8, 2021
A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunctionBobby G Ng, Paulina Sosicka, François Fenaille, et al.
Journal of Medical Genetics|September 29, 2017
Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literatureManuel Schiff, Céline Roda, Marie-Lorraine Monin, et al.
Pageof 5